Sorafenib (as tosylate)

1 Drug classified under this active ingredient

Protein Kinase Inhibitor. Sorafenib (as tosylate) 200 mg.
FC tab 30,120,360 x 200 mg. Recomm. dose in adults 400 mg sorafenib twice daily (total daily dose 800 mg).
Tmt. to continue as long as clin. benefit observ. or until unaccept. tox. occurs. See lit.
Adv. renal cell carc.
Hepatocellular carc.
Different. thyroid carc. with progr., locally adv. or metast., different. (papillary/follicular/Hürthle cell) thyroid carc., refract. to radioact. iodine.
C/I:Hypersens.